CoChat

Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey

Open access
Adam, Kai-Manuel, Osthoff, Michael, Lamoth, Frédéric, Conen, Anna, Erard, Véronique, Boggian, Katia, Schreiber, Peter W, Zimmerli, Stefan, Bochud, Pierre-Yves, Neofytos, Dionysios, Fleury, Mapi, Fankhauser, Hans, Goldenberger, Daniel, Mühlethaler, Konrad, Riat, Arnaud, Zbinden, Reinhard, Kronenberg, Andreas, Quiblier, Chantal, Marchetti, Oscar, Khanna, Nina, Fungal Infection Network of Switzerland (FUNGINOS), Bregenzer, Thomas, Conen, Anna, Adam, Kai-Manuel, Conen, Anna, Flückiger, Ursula, Khanna, Nina, Orasch, Christina, Heininger, Ulrich, Franciolli, Mario, San Giovanni, Ospedale, Damonti, Lauro, Zimmerli, Stefan, Rothen, Madeleine, Zellweger, Claudine, Rothen, Madeleine, Tarr, Philipp, Fleisch, Felix, Chuard, Christian, Erard, Véronique, Emonet, Stéphane, Garbino, Jorge, Neofytos, Dionysios, van Delden, Christian, Genne, Daniel, Bochud, Pierre-Yves, Calandra, Thierry, Damonti, Lauro, Erard, Véronique, Lamoth, Frédéric, Marchetti, Oscar, Orasch, Christina, Chave, Jean-Philippe, Bois-Cerf, Clinique, Cécil, Clinique, La Source, Clinique, Graber, Peter, Monotti, Rita, Regionale, Ospedale, Bernasconi, Enos, Civico, Ospedale, Rossi, Marco, Krause, Martin, Piso, Rein-Jan, Bally, Frank, Troillet, Nicolas, Boggian, Katia, Eich, Gerhard, Gubler, Jacques, Fehr, Jan, Imhof, Alexander, Ruef, Christian, Werner Schreiber, Peter, Eich, Gerhard, Gubler, Jacques, Berger, Christoph, Fankhauser, Hans, Heinzer, Ivo, Goldenberger, Daniel, Frei, Reno, Hertel, Roland, Dolina, Marisa, Petrini, Orlando, Dubuis, Olivier, Mühlethaler, Konrad, Graf, Suzanne, Risch, Martin, Ritzler, Eva, Fracheboud, Dominique, Riat, Arnaud, Rohner, Peter, Schrenzel, Jacques, Lienhardt, Reto, Bille, Jacques, Lamoth, Frédéric, Andreutti-Zaugg, Corinne, Gallusser, Alberto, Graf, Suzanne, Pfyffer, Gaby, Herzog, Karin, Schibli, Urs, Tissière, Lysiane, Bruderer, Thomas, Zbinden, Reinhard · 2021 · Open Forum Infectious Diseases

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Background: The increasing incidence of candidemia and emergence of drug-resistant Candida species are major concerns worldwide. Long-term surveillance studies are needed. Methods: The Fungal Infection Network of Switzerland (FUNGINOS) conducted a 15-year (2004–2018), nationwide, epidemiological study of candidemia. Hospital-based incidence of candidemia, Candida species distribution, antifungal susceptibility, and consumption were stratified in 3 periods (2004–2008, 2009–2013, 2014–2018). Population-based incidence over the period 2009–2018 derived from the Swiss Antibiotic Resistance Surveillance System (ANRESIS). Results: A total of 2273 Candida blood isolates were studied. Population and hospital-based annual incidence of candidemia increased from 2.96 to 4.20/100 000 inhabitants (P = .022) and 0.86 to 0.99/10 000 patient-days (P = .124), respectively. The proportion of Candida albicans decreased significantly from 60% to 53% (P = .0023), whereas Candida glabrata increased from 18% to 27% (P < .0001). Other non-albicans Candida species remained stable. Candida glabrata bloodstream infections occurred predominantly in the age group 18–40 and above 65 years. A higher proportional increase of C glabrata was recorded in wards (18% to 29%, P < .0001) versus intensive care units (19% to 24%, P = .22). According to Clinical and Laboratory Standards Institute, nonsusceptibility to fluconazole in C albicans was observed in 1% of isolates, and anidulafungin and micafungin nonsusceptibility was observed in 2% of C albicans and C glabrata. Fluconazole consumption, the most frequently used antifungal, remained stable, whereas use of mold-active triazoles and echinocandins increased significantly in the last decade (P < .0001). Conclusions: Over the 15-year period, the incidence of candidemia increased. A species shift toward C glabrata was recently observed, concurring with increased consumption of mold-active triazoles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ofid/ofab471

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. (A) Annual incidence of candidemia per 10 000 patient days in the 7 hospitals over the 3 time periods 2004–2008, 2009–2013, and 2014–2018. (B) Species distribution of Candida bloodstream isolates. Total number of Candida isolates per time period are indicated at the top.
Figure 1. (A) Annual incidence of candidemia per 10 000 patient days in the 7 hospitals over the 3 time periods 2004–2008, 2009–2013, and 2014–2018. (B) Species distribution of Candida bloodstream isolates. Total number of Candida isolates per time period are indicated at the top.CC BY-NC-ND · PubMed Central
Figure 2. (A) Species distribution of Candida bloodstream isolates according to patients’ age over 2004–2018 (4 hospitals). Total number of Candida isolates per age group are indicated at the top. (B) Species distribution of Candida bloodstream isolates according to patients’ location in the hospital over 2004–2018 (7 hospitals). Total number of Candida isolates per time period and ward are indicated at the top. Other Candida spp included (total numbers): Candida dubliniensis (n = 65), C lusitaniae (n = 20), Candida pelliculosa (n = 13), Candida kefyr (n = 11), Candida guilliermondii (n = 8), C norvegensis (n = 8), Candida africana (n = 5), Candida orthopsilosis (n = 4), Candida nivariensis (n = 4), Candida fabianii (n = 3), Candida inconspicua (n = 2), Candida palmioleophila (n = 2), Candida rugosa (n = 1), Candida pulcherrima (n = 1).
Figure 2. (A) Species distribution of Candida bloodstream isolates according to patients’ age over 2004–2018 (4 hospitals). Total number of Candida isolates per age group are indicated at the top. (B) Species distribution of Candida bloodstream isolates according to patients’ location in the hospital over 2004–2018 (7 hospitals). Total number of Candida isolates per time period and ward are indicated at the top. Other Candida spp included (total numbers): Candida dubliniensis (n = 65), C lusitaniae (n = 20), Candida pelliculosa (n = 13), Candida kefyr (n = 11), Candida guilliermondii (n = 8), C norvegensis (n = 8), Candida africana (n = 5), Candida orthopsilosis (n = 4), Candida nivariensis (n = 4), Candida fabianii (n = 3), Candida inconspicua (n = 2), Candida palmioleophila (n = 2), Candida rugosa (n = 1), Candida pulcherrima (n = 1).CC BY-NC-ND · PubMed Central
Figure 3. (A) Annual consumption of broad-spectrum antibiotics and antifungals in Defined Daily Doses (DDDs) per 100 patient days over 2004–2018. (B) Annual consumption of antifungals in DDDs per 100 patient days over 2004–2018. (C) Annual consumption of azoles in DDDs per 100 patient days over 2004–2018. Data of 7 hospitals are reported. Broad-spectrum antibiotics include the following: cefepime, piperacillin/tazobactam, imipenem, and meropenem. Antifungals include fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole, amphotericin B deoxycholate, liposomal amphotericin B, caspofungin, and anidulafungin. The DDDs were defined as follows: cefepime 4 grams, piperacillin/tazobactam 14 grams, imipenem 2 grams, meropenem 3 grams; fluconazole 0.4 grams, itraconazole 0.2 grams, voriconazole 0.4 grams, posaconazole 0.3–0.6 grams, isavuconazole 0.2 grams, amphotericin B deoxycholate 0.07 grams, liposomal amphotericin B 0.21 grams, caspofungin 0.05 grams, and anidulafungin 0.2 grams.
Figure 3. (A) Annual consumption of broad-spectrum antibiotics and antifungals in Defined Daily Doses (DDDs) per 100 patient days over 2004–2018. (B) Annual consumption of antifungals in DDDs per 100 patient days over 2004–2018. (C) Annual consumption of azoles in DDDs per 100 patient days over 2004–2018. Data of 7 hospitals are reported. Broad-spectrum antibiotics include the following: cefepime, piperacillin/tazobactam, imipenem, and meropenem. Antifungals include fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole, amphotericin B deoxycholate, liposomal amphotericin B, caspofungin, and anidulafungin. The DDDs were defined as follows: cefepime 4 grams, piperacillin/tazobactam 14 grams, imipenem 2 grams, meropenem 3 grams; fluconazole 0.4 grams, itraconazole 0.2 grams, voriconazole 0.4 grams, posaconazole 0.3–0.6 grams, isavuconazole 0.2 grams, amphotericin B deoxycholate 0.07 grams, liposomal amphotericin B 0.21 grams, caspofungin 0.05 grams, and anidulafungin 0.2 grams.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Public Health England., Heal Prot Rep

Cited by

See all 37

Metadata

Authors
Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., Fleury, M., Fankhauser, H., Goldenberger, D., Mühlethaler, K., Riat, A., Zbinden, R., Kronenberg, A., Quiblier, C., Marchetti, O., Khanna, N., Fungal Infection Network of Switzerland (FUNGINOS), Bregenzer, T., Conen, A., Adam, K.-M., Conen, A., Flückiger, U., Khanna, N., Orasch, C., Heininger, U., Franciolli, M., San Giovanni, O., Damonti, L., Zimmerli, S., Rothen, M., Zellweger, C., Rothen, M., Tarr, P., Fleisch, F., Chuard, C., Erard, V., Emonet, S., Garbino, J., Neofytos, D., van Delden, C., Genne, D., Bochud, P.-Y., Calandra, T., Damonti, L., Erard, V., Lamoth, F., Marchetti, O., Orasch, C., Chave, J.-P., Bois-Cerf, C., Cécil, C., La Source, C., Graber, P., Monotti, R., Regionale, O., Bernasconi, E., Civico, O., Rossi, M., Krause, M., Piso, R.-J., Bally, F., Troillet, N., Boggian, K., Eich, G., Gubler, J., Fehr, J., Imhof, A., Ruef, C., Werner Schreiber, P., Eich, G., Gubler, J., Berger, C., Fankhauser, H., Heinzer, I., Goldenberger, D., Frei, R., Hertel, R., Dolina, M., Petrini, O., Dubuis, O., Mühlethaler, K., Graf, S., Risch, M., Ritzler, E., Fracheboud, D., Riat, A., Rohner, P., Schrenzel, J., Lienhardt, R., Bille, J., Lamoth, F., Andreutti-Zaugg, C., Gallusser, A., Graf, S., Pfyffer, G., Herzog, K., Schibli, U., Tissière, L., Bruderer, T., & Zbinden, R.
Affiliations
  • University of Basel (CH)
  • Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich and University of Zurich, Zurich, Switzerland
  • Centre Hospitalier Universitaire Vaudois (CH)
  • University of Bern (CH)
  • University of Zurich (CH)
  • Kantonsspital Aarau (CH)
  • HFR Freiburg Kantonsspital (CH)
  • University of Geneva (CH)
  • Kantonsspital St. Gallen (CH)
  • University Hospital of Geneva (CH)
Venue
Open Forum Infectious Diseases
Published
2021-09-17
Volume
8
Issue
10
Pages
ofab471-ofab471
ISSN
2328-8957 (ISSN-L)
OpenAlex
W3199320884
Cited by
37
References
30
Citations by year
2026: 5 · 2025: 3 · 2024: 10 · 2023: 10 · 2022: 9
FWCI
2.30
Type
journal article
Language
en
Open access
Locations
  • Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by-nc-nd)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • IRIS (submittedVersion, cc-by-nc-nd)
  • BORIS (University Library Bern) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Open Access CRIS of the University of Bern
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Schering-Plough
  • Gilead Foundation
  • Merck and Sharp and Dohme
  • Novartis
  • Pfizer
  • Foundation for the Advancement in Medical Microbiology and Infectious Diseases
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
candidemia, Candida glabrata, Candida albicans, species shifts, antifungal resistance, fluconazole resistance, echinocandins, triazoles, candidemia incidence, bloodstream infection, intensive care unit, Switzerland, surveillance trends, non-albicans Candida, age distribution of infection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey. https://app.cochat.ai/papers/10.1093/ofid/ofab471
The paper
Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., Fleury, M., Fankhauser, H., Goldenberger, D., Mühlethaler, K., Riat, A., Zbinden, R., Kronenberg, A., Quiblier, C., Marchetti, O., . . . Zbinden, R. (2021). Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofab471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.